NDC 68001-651 – Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

Paclitaxel 100 mg/20mL · Injection, Powder, Lyophilized, For Suspension · Intravenous

Human Prescription Drug

Product NDC68001-651

Product details

Brand name
Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
Generic name
Paclitaxel
Labeler
BluePoint Laboratories
Dosage form
Injection, Powder, Lyophilized, For Suspension
Route
Intravenous
Marketing category
ANDA · ANDA216355
Marketed since
July 18, 2025
Listing expires
December 31, 2026
Pharmacologic class
Microtubule Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Paclitaxel protein-bound particles for injectable suspension (albumin-bound) →

Package NDC codes (1)

Package NDCDescriptionSince
68001-651-371 VIAL, SINGLE-USE in 1 CARTON (68001-651-37) / 20 mL in 1 VIAL, SINGLE-USEJul 18, 2025

Other Paclitaxel protein-bound particles for injectable suspension (albumin-bound) products